{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-093197","form_type":"8-K","ticker":"ESLA","cik":"0001844417","company_name":"Estrella Immunopharma, Inc.","filed_at":"2025-09-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.317467+00:00","generated_at":"2026-05-17T05:26:36.209816+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Estrella Immunopharma regains Nasdaq compliance on bid price and market value","bullets":["Regained compliance with Nasdaq minimum bid price rule (5550(a)(2)) after 10 consecutive days of closing bid ≥ $1.00 (Sept 9-22, 2025).","Regained compliance with Nasdaq minimum market value of listed securities rule (5550(b)(2)) after 17 consecutive days of MV ≥ $35M (Aug 28-Sept 22, 2025).","Both compliance matters are now closed; previously disclosed non-compliance resolved."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-093197","json":"https://secwatch.observer/filing/0001213900-25-093197.json","markdown":"https://secwatch.observer/filing/0001213900-25-093197.md","text":"https://secwatch.observer/filing/0001213900-25-093197.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844417/000121390025093197/0001213900-25-093197-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844417/000121390025093197/ea0259355-8k_estrella.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:26:36.209816+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}